Daniel J. Curran - 12 Aug 2025 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
Director
Signature
/s/ Shelly Pinto, by power of attorney
Issuer symbol
ALXO
Transactions as of
12 Aug 2025
Net transactions value
$0
Form type
4
Filing time
13 Aug 2025, 16:47:50 UTC
Previous filing
08 Aug 2025
Next filing
24 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Curran Daniel J. Director C/O ALX ONCOLOGY HOLDINGS INC., 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO /s/ Shelly Pinto, by power of attorney 13 Aug 2025 0001887599

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALXO Stock option (right to buy) Award $0 +40,400 $0.000000 40,400 12 Aug 2025 Common Stock 40,400 $0.6150 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares subject to the option vest in 36 equal monthly installments beginning on September 12, 2025.